Log in

Register Subscribe
The Home of Textile Innovation

MEDFORD – Silk Therapeutics, a specialty biomaterials company, today announced the conclusion of a US$21 million deal to fund the company’s ‘liquid silk’ development programme for applications in both the textile and skincare sectors. The move sees investor, Jeff Vinik, owner of the Tampa Bay Lightning, join the board.

The deal has been hailed as a “massive milestone that validates our ongoing efforts to leverage natural liquid silk to replace unregulated chemicals in common consumer products," said Silk Therapeutics chief executive officer, Greg Altman.

Why Subscribe?


Trending Right Now

Weekly e-news bulletin

Latest news direct to your inbox

Interested in advertising?

Simply give us a call

Sales: +44 1977 708488

Or if you prefer email, click on the button below and we'll get back to you asap


Why Subscribe?

Looking beyond the cutting edge of textile innovation allows you to stay well ahead of the competition. That’s exactly what you get through a subscription to T.EVO – which delivers a refreshing new take on the rapid evolution of today’s dynamic textile sector.

Key T.EVO benefits:

You will learn about:

All this from MCL Global – the fastest growing international textile publisher – which can now offer today’s textile industry a unique preview of how today’s industry will look tomorrow.

In print, online and mobile device formats.